Clinical Trial Update: Survival Rate and Treatment Cost in Patients With Pancreatic Cancer: An Analysis Using NHIS Database and K-PaC Registry Focusing on Liposomal Irinotecan

View source ↗

Summary

A completed clinical trial analyzing survival rates and treatment costs for pancreatic cancer patients treated with liposomal irinotecan, using NHIS and K-PaC r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Onivyde (irinotecan hydrochloride liposome injection)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Pancreatic Cancer | Status: COMPLETED